Formulation, Optimization and Pharmacodynamic Studies of Pioglitazone HCl Solid Lipid Nanoparticles
Y. Indira Muzib, E. Ramya & Y. R. Ambedkar · Journal of Pharmaceutical Research International · 2021
Pioglitazone HCl is an oral anti-diabetic agent used for the treatment of diabetes mellitus type II. The aim of the present work is to evaluate the pharmacodynamic activity of solid lipid nanoparticles of pioglitazone HCL prepared by using solvent injection technique and to compa...
Open access
Research Article
10.9734/jpri/2021/v33i46A32873